Short answer
Kodiak Sciences Inc. (KOD) filed an 8-K current report with the SEC on August 13, 2026 reporting Item 2.02 (Results of Operations and Financial Condition), Item EX-99.1 (Exhibit EX-99.1). Q2 2026 financial results and business highlights reported for quarter ended June 30, 2026.
Kodiak Sciences Inc. 8-K event analysis
AI summary of each reported item and its exhibits
Item 2.02 · Results of Operations and Financial Condition
- Q2 2026 financial results and business highlights reported for quarter ended June 30, 2026
- Full financial details and operating developments contained in Exhibit 99.1 press release
- Disclosure furnished under Regulation FD, limiting Exchange Act Section 18 liability
Item EX-99.1 · Exhibit EX-99.1
- Q2 2026 net loss $65.6M, or $1.05 per share, versus $54.3M and $1.03 in Q2 2025
- Cash $125.9M, down from $209.9M at December 31, 2025; management expects funding into 2027
- R&D spending rose to $56.1M from $42.8M, reflecting expanded PEAK/PINNACLE trials and Phase 3 manufacturing
- September 2026 DAYBREAK topline data represent near-term pivotal catalysts for Zenkuda and KSI-501 in wet AMD
- December 2026 PEAK results and ALTO enrollment expand the late-stage pipeline but increase execution and financing risk
Generated from the filing text and exhibits; verify against the original. What 8-K item codes mean
Other Kodiak Sciences Inc. 8-K filings
Get the next KOD 8-K as it lands
Follow KOD for push alerts, or ask the research agent what this filing means.